Ferring's novel first-in-class REBYOTA is indicated for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older, following antibiotic treatment
WASHINGTON (dpa-AFX) - The U.S. Food and Drug Administration said it has granted approval for Ferring Pharmaceuticals Inc.'s fecal microbiota product Rebyota.The approval is for the prevention
Although I’ll be the one leaving this time, with my graduation more looming than his, I’m glad that he is still here for me. Even after we both move away, I know he’ll still be there.